Peania, September 29th, 2017 – In the First Half of 2017, Lavipharm reports increased Consolidated Turnover mainly attributed to international sales, despite economic pressures, sustained regulatory constraints and decrease of the pharmaceutical market in Greece. At the same time, the sharp drop in loans and...
For the 9th consecutive year, Lavipharm employees, sponsored by the company, run for a cause at the 35th Athens Marathon the Authentic that took place on Sunday, November 12th. A human river with more than 51,000 participants from all over Greece and 105 countries around...
The conference, entitled "Pharmacy: Entrepreneurship & Health Communication", aimed at pharmacists, assistants, sales and marketing companies executives and those who are active in the pharmacy area. It is estimated that it attracted over 2,000 visitors, representatives of the pharmaceutical market. Pharma PLUS had a double participation...
The new corporate website incorporates the experience, knowledge and values of the 100-year operation of the company and its evolution between the two centuries (1911-2011). It unfolds the history of the company, through milestone events that marked its course. Lavipharm, which started as a family...
In this environment, Lavipharm mainly focused on the enhancement of its export activities. At the same time, despite the constant twists and instability that prevailed and obstructed the business plans, the Company followed a long-term plan to boost sales in the domestic market and to...
Lavipharm has entered into a cooperation agreement with the Belgian medical plant specialist Tilman in the sector of plant based pharmaceutical products. Tilman is one of the largest companies in Europe and its plant originated products are marketed in 30 countries around the world. Tilman laboratories,...
